Panayotis Kaloyannidis

Dr. Panayotis Kaloyannidis Specialist Hematologist


Years of Experience : 25

Nationality : Greece

Languages Known : English, Greek

Book Appointment

Biography

Dr. Panayotis Kaloyannidis has joined Burjeel Medical City as Specialist Hematologist in the Adult Hematology and Bone Marrow Transplant department. He has 25 years of experience, mainly in the field of malignant hematological diseases and their treatment with conventional chemotherapy and cellular therapies, including hemopoietic stem cell transplantation. Since 1998 he has been actively involved in more than 2000 hematopoietic stem cell transplants (autologous and allogeneic) from any source of hematopoietic cells (bone marrow, peripheral blood, and umbilical cord blood). In 2012-2013 he was trained in cellular therapies with chimeric antigen receptors T cells (CAR T-cells) and specific T-cells against viral infections and relapse post allogeneic stem cell transplantation. His Expertise and areas of interest include diagnosis and treatment of malignant hematological diseases, hematopoietic stem cell transplantation, post-transplantation complications (Graft vs. Host disease, infections, relapsed disease), cellular therapies, and immunotherapy for malignant hematological diseases. Dr. Kaloyannidis has held a senior Consultant Hematologist position at the Department of Hematology and Bone Marrow Transplantation Unit at the “G. Papanicolaou” General Hospital in Thessaloniki, Greece, from 1998-2014 and as a senior Consultant Hematologist at the Adult Oncology/Hematology and SCT department at King Fahad Specialist Hospital-Dammam, S. Arabia from  June 2014-  March 2023. Dr. Kaloyannidis is a member of the Hellenic Society of Hematology, the European Society for Bone Marrow Transplantation (EBMT), and the Saudi Society of Blood and Marrow Transplantation (SSBMT). His areas of expertise include,

  • Diagnosis and Treatment of Malignant Hematological Diseases
  • Hematopoietic Stem Cell Transplantation and Post-Transplantation complications (Graft vs. Host disease, Infections, Relapsed Disease),
  • Cellular Therapies and Immunotherapy for Malignant Hematological Diseases

Research & Publications

  • Kaloyannidis P, Omari R, Eldebawy E, Al Shaibani E, Apostolidis J, Hindi T, Raslan H, Al Garni A, Al Buali A, Al Anezi K, Al Hashmi H. Favorable outcome after adjuvant involved -field radiotrherapy after autologous hematopoietic tem-cell transplantation in high risk relapsed/refractory lymphoma: a single center experience. Clin Lymphoma Myeloma Leuk. 2020 Sep 19: doi: 10.1016/j.clml.2020.08.028
  • Kaloyannidis P, Omari R, Eldebawy E, Al Shaibani E, Apostolidis J, Hindi T, Raslan H, Al Garni A, Al Buali A, Al Anezi K, Al Hashmi H. Favorable outcome after adjuvant involved -field radiotrherapy after autologous hematopoietic tem-cell transplantation in high risk relapsed/refractory lymphoma: a single center experience. Clin Lymphoma Myeloma Leuk. 2020 Sep 19: doi: 10.1016/j.clml.2020.08.028
  • Kaloyannidis P, Al Shaibani E, Apostolidis I, Kafnar S, Al Anezi K, Al Hashmi H. Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease. Bone Marrow Transplant. 2019; May ;54: 746-748 doi: 10.1038/s41409-018-0362-7
  • Kaloyannidis P, Al Shaibani E, Mashhour M, Gamil M, Apostolidis I, Al Hashmi H, Al Anazi K. De novo Psoriasis Vulgaris diagnosed after Nivolumab treatment for refractory Hodgkin lymphoma, completely resolved after autologous hematopoietic stem cell transplantation. Case Rep Hematol. 2018 Oct 16; doi: 10.1155/2018/6215958

Education & Training

  • University of Ioannina, Greece: Medical School, Specialization in Hematology 1988
  • Training in Cellular Therapies for Relapsed Disease and Infectious Diseases Post Hematopoietic Stem Cell Transplantation, Cell and Gene Therapy Center, Baylor College of Medicine, Houston, Texas, USA, 2012-2013

Membership

  • Hellenic society of Hematology
  • European Society for Bone Marrow Transplantation (EBMT)
  • Saudi Society of Blood and Marrow Transplantation (SSBMT)

Blogs